company logo

National Sales Director in San Antonio, TX

Myriad Genetics, Inc

San Antonio, TX 78201
and 8 other locations
6w ago


Sales Management & Operations, Sales


8 - 10 years

Job Description


The NSD will work with other Commercial entities in development and implementation of a National Sales strategy that will focus on optimizing the sales and account management effort. This will acknowledge a territory lifecycle where a balance of selling and account management will be in flux as a territory matures. The sales organization will engage in selling activities with the goal of familiarizing and promoting to the audience and building the need for Vectra Guided Care for patients with Rheumatoid Arthritis. Post adoption, the sales organization will add logistical support to ensure any tests submitted by an HCP are handled efficiently and provide clinical review and support for interpretation of results. They will also be continually educating HCP's on new data and publications relating to optimal use of Myriad Autoimmune diagnostics. Primary selling activity includes, but not limited to, the following:

  • Selling the
See More

Valid through: 2020-3-4

About Myriad Genetics

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individuals risk for developing disease later in life (predictive medicine), identify a patients likelihood of responding to a particular drug therapy (personalized medicine), assess a patients risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriads discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: “There is no more exciting story in medical science.” Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics. In August 2016 Myriad announced it would acquire Assurex Health for up to $410 million, expanding the companys genetic testing for psychotropic medicine selection. The global search for the genetic basis of breast and ovarian cancers began in earnest in 1988. In 1990, at an American Society of Human Genetics Meeting, a team of scientists led by Mary-Claire King, Ph.D., from University of California, Berkeley announced the localization through linkage analysis of a gene associated with increased risk for breast cancer (BRCA1) to the long arm of chromosome 17. In August 1994, Mark Skolnick and researchers at Myriad, along with colleagues at the University of Utah, the U.S National Institutes of Health (NIH), and McGill University sequenced BRCA1. In 2013, the actress Angelina Jolie had her ovaries removed because she tested positive for a mutation in the BRCA1 gene. This led to a surge in demand by women for genetic testing.
Total Jobs:
Total Experts:
Average Pay:
Total value of jobs:
% Masters:

Myriad Genetics Photos

company social media photocompany social media photocompany social media photocompany social media photo
* Ladders Estimates